1. Home
  2. FN vs ROIV Comparison

FN vs ROIV Comparison

Compare FN & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FN
  • ROIV
  • Stock Information
  • Founded
  • FN 1999
  • ROIV 2014
  • Country
  • FN Cayman Islands
  • ROIV United Kingdom
  • Employees
  • FN N/A
  • ROIV N/A
  • Industry
  • FN Telecommunications Equipment
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • FN Utilities
  • ROIV Health Care
  • Exchange
  • FN Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • FN 8.3B
  • ROIV 8.4B
  • IPO Year
  • FN 2010
  • ROIV N/A
  • Fundamental
  • Price
  • FN $227.44
  • ROIV $10.94
  • Analyst Decision
  • FN Buy
  • ROIV Strong Buy
  • Analyst Count
  • FN 8
  • ROIV 8
  • Target Price
  • FN $255.63
  • ROIV $17.93
  • AVG Volume (30 Days)
  • FN 420.8K
  • ROIV 5.3M
  • Earning Date
  • FN 02-03-2025
  • ROIV 02-11-2025
  • Dividend Yield
  • FN N/A
  • ROIV N/A
  • EPS Growth
  • FN 25.19
  • ROIV N/A
  • EPS
  • FN 8.45
  • ROIV 5.89
  • Revenue
  • FN $3,001,718,000.00
  • ROIV $129,128,999.00
  • Revenue This Year
  • FN $18.42
  • ROIV $15.98
  • Revenue Next Year
  • FN $13.18
  • ROIV N/A
  • P/E Ratio
  • FN $26.91
  • ROIV $1.86
  • Revenue Growth
  • FN 12.20
  • ROIV 145.68
  • 52 Week Low
  • FN $159.69
  • ROIV $9.69
  • 52 Week High
  • FN $278.38
  • ROIV $13.06
  • Technical
  • Relative Strength Index (RSI)
  • FN 48.43
  • ROIV 38.75
  • Support Level
  • FN $216.78
  • ROIV $10.42
  • Resistance Level
  • FN $240.51
  • ROIV $11.82
  • Average True Range (ATR)
  • FN 7.06
  • ROIV 0.35
  • MACD
  • FN 0.86
  • ROIV -0.11
  • Stochastic Oscillator
  • FN 53.65
  • ROIV 29.21

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: